Physician Assistant, Medical · Greensburg, PA
NPI
1265539977
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
530 South St, Suite 300
Greensburg, PA, 15601
Phone (724) 832-3130
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.8M
9,320 prescriptions
Company payments, 2025
$2,876
From 25 companies
Medicare prescription drug claims, 2024
In 2024, the drug Sherry Basile prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,288 prescriptions and refills. In total Sherry Basile wrote 9,320 Medicare prescriptions that cost $3.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-09-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 1,288 | 2,652 | 272 | $13K |
| Ozempic Semaglutide | 1,078 | 1,281 | 190 | $1.2M |
| Metformin Hcl Generic | 431 | 965 | 102 | $2,905 |
| Jardiance Empagliflozin | 431 | 689 | 85 | $389K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 348 | 652 | 100 | $40K |
| Metformin Hcl Er Metformin Hcl | 305 | 655 | 76 | $4,706 |
| Synthroid Levothyroxine Sodium | 292 | 612 | 64 | $16K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 253 | 518 | 97 | $19K |
| Farxiga Dapagliflozin Propanediol | 220 | 358 | 49 | $195K |
| Trulicity Dulaglutide | 186 | 234 | 46 | $218K |
| Novolog Flexpen Insulin Aspart | 181 | 305 | 59 | $48K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 180 | 240 | 47 | $201K |
| Mounjaro Tirzepatide | 172 | 178 | 48 | $182K |
| Humalog Kwikpen U-100 Insulin Lispro | 167 | 219 | 46 | $38K |
| Pioglitazone Hcl Generic | 156 | 265 | 30 | $2,089 |
Brand drugs: 5,026 claims; generic drugs: 3,365 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherry Basile $2,876 ($2,876 in general payments such as food, travel and fees) from 25 companies. The largest payer was CeQur Corporation with $449.
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $449 |
| Novo Nordisk Inc NVO | 18 | $326 |
| Mannkind Corporation MNKD | 15 | $267 |
| Lilly USA, LLC LLY | 11 | $213 |
| Xeris Pharmaceuticals, Inc. | 7 | $160 |
| Dexcom, Inc. DXCM | 9 | $153 |
| Madrigal Pharmaceuticals MDGL | 10 | $138 |
| Medtronic, Inc. MDT | 4 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $119 |
| Sanofi-Aventis U.S. LLC SNY | 5 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.